Aevum is pioneering the discovery and development of therapeutic molecules derived from exercised muscle to treat diseases that are known to benefit from exercise. Our lead program is being developed for the treatment of Parkinson’s disease and other related neurodegenerative disorders.
Focus/Therapeutic Area:
Neurology
Stage/Status:
Seed
Website:
—